PARVOVAX
PARVOVAX
Authorised
- Porcine parvovirus, Inactivated
Product identification
Medicine name:
PARVOVAX
Active substance:
- Porcine parvovirus, Inactivated
Target species:
-
Pig (for reproduction)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine parvovirus, Inactivated
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig (for reproduction)
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1134836 8/1988
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
